
Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>



































R-PE Antibody Labeling Kit uses a simple and quick process for PE conjugation of antibody. The conjugated antibody can be used straight away without further purification step and antibody loss.
It is for research use only.

| ID | Components | Size |
| ALK01-C01 | Modifier reagent | 1 vial |
| ALK01-C02 | Activated PE | 1 vial |
| ALK01-C03 | Quencher reagent | 1 vial |
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

2.5e5 RC222 cells (anti-CD19 CAR-293 cells, G4S linker is used in CARs) and jurkat cells (with expression of the CD3 antigen) were stained with 100μL of 1μg/mL PE labeled antibody, and analyzed with FACS.
The results show ALK-A001 can be used for different antibodies conjugation.

Binding signal of products prepared by different size of PE antibody labeling Kit (ALK-A001). The result shows very high consistency (QC tested).

The binding signal of PE labeled anti-FMC63 antibody using ALK-A001 Kit was higher than the other competitor kit (Routinely tested).

The binding signal of PE labeled anti-CD3 antibody using ALK-A001 Kit was higher than the other competitor kit (Routinely tested).
Emerging VoCs, Omicron, Delta, Beta, Alpha mutants and so on, including RBD, S trimer, S1, NTD, NP, etc. These mutants are of high purity and bioactivity and can be used to evaluate the efficacy of the antibodies and vaccination.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.
CD3 proteins and a collection of for bispecific antibody development which are of high specificity and bioactivities and suitable for immunization, antibody screening.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
The MABSOL biotinylated protein collection includes more than a hundred commonly studied drug targets and biomarker proteins.
Comprehensive cytokines including IL families, growth factors, chemokines, TNFs, etc. These products are HEK293 expressed and nearly in authentic structure, high purity and bioactivity, cell based assay/SPR/BLI verified.
To support preclinical/clinical immunogenicity and PK analysis, ACROBiosystems has developed a series of high-affinity anti-idiotypic antibodies. Our pipeline covers five hot targets including adalimum*b, rituxim*b, cetuxim*b, trastuzum*b, and bevacizum*b.
| English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|
| English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|
This web search service is supported by Google Inc.




